Helping people to use leading technologies to learn and achieve more, creating a smarter and more sustainable world.
Five young engineers, including TumourVue founder Dr Gita Khalili Moghaddam, have each received a prestigious award and a £3,000 prize from the Royal Academy of Engineering for achieving early success in their career. They were presented with their awards from HRH The Princess Royal, Royal Fellow of the Academy, during a specially arranged visit to […]
July 14, 2021
A lion at Five Sisters Zoo (West Calder, Scotland) has become the first animal in the world to have dental surgery using a revolutionary regional anaesthesia device developed by NHS clinicians. Susan Thorne, Clinical Director of DentalVets, carried out the root canal procedure on the lion, who had two teeth extractions. The pioneering medical device […]
June 11, 2021
Medovate, a dynamic medical device company dedicated to the development and commercialisation of innovative medical technologies, and Vygon Group, a group specialising in single-use medical devices, today announce that they have signed an exclusive deal to distribute SAFIRA® (SAFer Injection for Regional Anaesthesia) across 60 countries.
December 20, 2020
Cambridge-based Ablatus Therapeutics Limited has been awarded £1.4m by the UK government’s Innovate UK to develop its next-generation, minimally-invasive treatment for soft tissue tumours. The award will fund a 2-year project to develop the prototype device into a final version for use in patients for the first time.
December 18, 2020
Medtech Accelerator, a joint venture between innovation hub Health Enterprise East (HEE), Eastern AHSN (Academic Health Science Network) and regional business partners to support medtech pioneers, has announced an award of £125,000 to Cambridge-based company NeutroCheck, to progress development of an at-home safety monitoring test for chemotherapy patients.
December 17, 2020
A pioneering endoscopic surgical device, backed by the Medtech Accelerator, has been licensed to medical device company Medovate who will be responsible for bringing it to market. The new device, ENDOVAC, has the potential to dramatically improve survival of patients with life threatening infection following a leak from the upper gastrointestinal (GI) tract whilst significantly enhancing current treatment methods.
December 16, 2020
NVM Private Equity (“NVM”) has invested £1.0 million of growth capital into Cambridge-based medical device company Ablatus Therapeutics (“Ablatus”) alongside existing angel investors and the Medtech Accelerator.
December 11, 2020
Uncovering the latest innovative healthcare technology with the first Medtech Accelerator Health Hack.
December 6, 2020